Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T

Proton MR spectroscopic imaging (1H‐MRSI) of the human prostate, which has an interesting clinical potential, may be improved by increasing the magnetic field strength from 1.5T to 3T. Both theoretical and practical considerations are necessary to optimize the pulse timing for spectroscopic imaging of the human prostate at 3T. For in vivo detection of the strongly coupled spin system of citrate, not only should the spectral shape of the signal be easy to identify, but the timing used should produce MR signals at reasonably short echo times (TEs). In this study the spectral shape of the methylene protons of citrate was simulated with density matrix calculations and checked with phantom measurements. Different calculated optimal spectral shapes were measured in patients with prostate cancer with a 2D spectroscopic imaging sequence. T1 and T2 relaxation times were calculated for citrate and choline, the two major metabolites of interest in the prostate. We conclude that the optimum timing for in vivo point‐resolved spectroscopy (PRESS) imaging at 3T is an interpulse timing sequence of 90° ‐ 25 ms ‐ 180° ‐ 37.5 ms ‐ 180° ‐ 12.5 ms ‐ echo. A short repetition time (TR) of 750 ms partially saturates choline signals, but increases the SNR per unit time for citrate, and accommodates a maximum number of weighted averages of an elliptically sampled k‐space for accurate localization and minimal contamination of the individual spectra. This is illustrated by means of a 3D spectroscopic imaging experiment in a complete prostate in vivo. Magn Reson Med 53:1268–1274, 2005. © 2005 Wiley‐Liss, Inc.

[1]  Michael Garwood,et al.  Solvent Suppression Using Selective Echo Dephasing , 1996 .

[2]  Michael Garwood,et al.  In vivo quantification of choline compounds in the breast with 1H MR spectroscopy , 2003, Magnetic resonance in medicine.

[3]  S. Blackband,et al.  Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences , 1996, Magnetic resonance in medicine.

[4]  R. B. Kingsley,et al.  WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. , 1994, Journal of magnetic resonance. Series B.

[5]  M. van der Graaf,et al.  Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin‐echo pulse sequence , 1997, Magnetic resonance in medicine.

[6]  A. Heerschap,et al.  Removal of the outer lines of the citrate multiplet in proton magnetic resonance spectra of the prostatic gland by accurate timing of a point-resolved spectroscopy pulse sequence , 1997, Magnetic Resonance Materials in Physics, Biology and Medicine.

[7]  H. Hricak,et al.  Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging , 2000, Magnetic resonance in medicine.

[8]  R Pohmann,et al.  Accurate phosphorus metabolite images of the human heart by 3D acquisition‐weighted CSI , 2001, Magnetic resonance in medicine.

[9]  P. Bottomley Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[10]  Dennis W J Klomp,et al.  Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.

[11]  Citrate signal enhancement with a homonuclear J‐refocusing modification to double‐echo PRESS sequences , 1996, Magnetic resonance in medicine.

[12]  Robert V. Mulkern,et al.  Density matrix calculations of AB spectra from multipulse sequences: Quantum mechanics meets In vivo spectroscopy , 1994 .

[13]  van der Graaf M,et al.  Effect of Cation Binding on the Proton Chemical Shifts and the Spin-Spin Coupling Constant of Citrate , 1996, Journal of magnetic resonance. Series B.

[14]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[15]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.

[16]  J. Kurhanewicz,et al.  Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. , 2001, Urology.

[17]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[18]  J. Kurhanewicz,et al.  Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.

[19]  J C Gore,et al.  Density matrix simulations of the effects of J coupling in spin echo and fast spin echo imaging. , 1999, Journal of magnetic resonance.

[20]  J. Pauly,et al.  Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm [NMR imaging]. , 1991, IEEE transactions on medical imaging.

[21]  M. van der Graaf,et al.  In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.

[22]  Thomas H. Mareci,et al.  Experimental study of optimal selective 180° radiofrequency pulses , 1988 .

[23]  Michael Erb,et al.  Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla , 2003, Magnetic resonance in medicine.